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Abstract
Exposure to high levels of early life stress has been identified as a potent risk factor for 
neurodevelopmental delays in infants, behavioral problems and autism in children, but also for 
several psychiatric illnesses in adulthood, such as depression, anxiety, autism, and posttraumatic 
stress disorder. Despite having robust adverse effects on both mother and infant, the 
pathophysiology of peripartum depression and anxiety are poorly understood. The objective of this 
review is to highlight the advantages of using an integrated approach addressing several 
behavioral domains in both animal and clinical studies of peripartum depression and anxiety. It is 
postulated that a greater focus on integrated cross domain studies will lead to advances in 
treatments and preventative measures for several disorders associated with peripartum depression 
and anxiety.
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1. INTRODUCTION
Women commonly experience depressive and anxiety disorders during reproductive years 
[1]. Annually, nearly one-half million infants are born to mothers with depression [2]. 
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Approximately 18.4% of women suffer from antepartum depression, and approximately 
19.2% of mothers develop a depressive disorder within several weeks of delivery [3]. 
Depression during pregnancy is a major risk factor for postpartum depression [4]. 
Peripartum depression (PPD), occurring during pregnancy or within a short time after 
delivery, is a risk factor for maternal suicide which accounts for up to 20% of postpartum 
deaths in depressed women [5]. Peripartum anxiety disorders are also common, with a 
prevalence rate of 21.7% during the 3rd trimester of pregnancy, and 11.1% during the first 3 
postpartum months [6, 7]. PPD and anxiety are associated with a diverse array of adverse 
effects on offspring, spanning from birth to adulthood, and are often comorbid [8]. A 
growing literature supports the hypothesis that PPD and anxiety are risk factors for the later 
development of psychiatric disorders in offspring. The temporal specificity of PPD and 
anxiety, combined with how these highly comorbid disorders may lead to transmission of 
psychiatric phenotypes in offspring make this topic ideal for cross domain research [9]. 
Although PPD is associated with several disorders and the preventative potential of focusing 
on this area for enhancing the health of offspring and future generations is great, there are 
few animal models devoted to this topic. Whilst clinical phenotyping of PPD and anxiety 
has improved, most animal models still focus on a relatively small subset of symptoms. And 
compared to the available animal literature on depression and anxiety in males, there is 
staggeringly little attention paid to female-specific symptomology, with even less attention 
paid to the maternal transition itself.
The overlapping symptomatology domains of PPD and anxiety are not novel; however, the 
idea that treatments could be improved by targeting several symptoms has received greater 
attention recently. Deficiencies in maternal care may not necessarily be ameliorated by 
classic antidepressant treatments such as SSRI’s which can be effective at decreasing 
general anhedonia. This therefore indicates a need for the assessment of both depression 
symptoms and maternal care [9–13], especially since many of the adverse effects of PPD 
and anxiety on offspring are mediated through maternal care [14]. Aggression and hostility 
are also concerns with respect to how PPD and anxiety affect family dynamics (increasing 
family conflict and adverse parental behaviors) even when there is little risk of physical 
aggression towards offspring [15–18]. Therefore, considering the behavioral ‘phenotype’ of 
the entire family may be an effective treatment option [18]. Two other behavioral domains 
that should be considered in both research and treatment of PPD and anxiety are 
restlessness/agitation and impaired concentration and decision making, which are more 
prevalent in PPD than non-maternal depression [19]. Another important phenotypic factor 
that mediates many of the socio-economic and cultural differences in rates of maternal mood 
disorders is social environment and behavior. In general, women with low levels of social 
support are at an increased risk for PPD and anxiety and increased social support has 
beneficial effects in depressed mothers [20–25].
The use of a cross domain approach with PPD and anxiety should aid in the understanding 
of specific physiological endophenotypes involved in these disorders. For example, although 
oxytocin (OXT) is known to be involved in anxiety, social affiliation, and the physiological 
processes of parturition and lactation, research on PPD is just starting to focus on the OXT 
system despite the observations that depressed mothers are likely to be anxious and have 
difficulties with infant bonding as well as impaired lactation. Depressed and anxious 
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mothers often have difficulties nursing and are more likely to stop nursing earlier [26, 27], a 
behavior highly dependent on the OXT system. Premenstrual dysphoric disorder (PMDD) 
and a past history of depressive symptoms during past oral contraceptive use are two other 
risk factors for PPD, suggesting that the general domain of non-maternal reproductive 
endocrinology difficulties should be considered in research and treatment of PPD and 
anxiety [28–31]. Depression and anxiety in women undergoing assisted reproductive 
techniques may have a significant endocrine component and not simply be a result of the 
stress associated with the process [32, 33]. Furthermore, social deficits in both the mother 
and infant could also be associated with the OXT system. Therefore, although not 
commonly represented in animal models, dysregulation of the OXT system is a potential 
endophenotype of PPD and anxiety, and translational neuroscience could benefit from the 
inclusion of this system in study designs.
In this review, a novel animal model of PPD and anxiety and the advantages of the cross-
domain research approach using this model are discussed. The authors propose that 
modeling phenotypic clusters (i.e. cross domain) clinically observed within peripartum 
maternal depression and anxiety and infant/child neurodevelopment can be useful for 
translational neuroscience. We begin by describing how such phenotypic clusters (or 
behavioral domains) are assessed (section 1.1.), then describe the potential advantages of 
using an animal model in a cross domain approach to study the negative consequences of 
PPD and anxiety on both mother and offspring (section 2). The subsequent sections then 
review how PPD and anxiety may increase the risk of depression and anxiety (section 3), 
autism spectrum disorders (section 4), and posttraumatic stress disorder (section 5) in the 
offspring of depressed and anxious mothers through discussion of the multiple domains 
affected by PPD and anxiety and the few cross domain studies on these topics. We then 
summarize and discuss these topics, and provide some conclusions and suggestions for 
future directions of the field.
1.1 Assessing phenotypic clusters within peripartum maternal depression and anxiety and 
infant/child neurodevelopment
Many domains of behavior which have been modeled in animals have been examined in 
humans, some studied in depression/anxious peripartum women and others focused on their 
exposed infants/children. Since a main limitation of human studies is the inability to directly 
examine neurochemistry and neurocircuitry in human pregnant mothers and infants, research 
has focused on physiology, development and self-reported or observed symptomatology. 
Clinical research is moving towards the increased study of phenotypic clusters [34] and 
away from the study of ‘pure’ diagnoses since many psychiatric syndromes represent a 
spectrum of illness inclusive of abnormalities in several overlapping domains of behavior 
and physiology. The best examined domains/systems in depressed/anxious peripartum 
women include negative valence, cognitive systems and perception of self/others while 
those best studied in depression/anxiety exposed infants/children involve studies of fear, 
anxiety, attention, attachment formation, cognition and perception of self/others. Few 
clinical studies have examined positive valence systems and arousal/modulatory systems 
(i.e. circadian rhythms). Clinical research studies are lacking in understanding the 
underlying pathophysiology of peripartum depressive/anxiety disorders and how 
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psychopathology is transmitted to the offspring. Likewise, the adverse neurodevelopmental 
effects on infants and children as measured by clinical testing are well examined, but the 
underlying causes and the longitudinal course of these deficits across childhood into 
adulthood are poorly understood. One approach is to develop animal models of peripartum 
depression/anxiety based on an aggregate of behavioral domains common to anxiety/
depression e.g. negative or positive valence systems. In the offspring one can then study 
domains shown to be affected by human peripartum depression/anxiety which are 
observable in animal models e.g. fear, anxiety, attention. Using an aggregate of domains 
which cluster in both depressive and anxiety disorders allows the study (i.e. at the genetic, 
molecular, cellular, circuit, physiology and behavior levels) of pathophysiology along a 
continuum. Understanding the underpinnings of clusters of behavioral domains allows 
investigators to then compare and contrast similarities and differences to psychiatric 
illnesses characterized by shared or differing clusters. While certain types of analysis will be 
easier studied in humans than non-human animals and vice versa, translational neuroscience 
will be instrumental to provide evidence for the validity of target genes identified in human 
studies using peripheral blood samples [35], examine transmission of psychopathology risk 
at the molecular and cellular levels and to examine neurocircuitry for each phenotypic 
cluster, across species [36].
2. TOWARDS AN INTEGRATIVE CROSS-DOMAIN ANIMAL MODEL OF PPD 
AND ANXIETY
It has been postulated that animal models that include multiple domains of neuropsychiatric 
models and the appropriate etiological and interactive context will have greater construct 
validity and clinical relevance [37]. Current animal models for many disorders often fail to 
include multiple associated symptom domains. The lack of efficacy with modern treatments 
for depression may be due to the incorrect assumption that abstract behavioral tests such as 
forced swim, tail-suspension, and saccharin preference are appropriate analogues for human 
depression [38]. These tests have produced treatments which do not work much better than 
placebo for mild and moderate depression [39, 40] and need to be replaced with more 
ethological paradigms. A further complication with the translation of much of the animal 
research on depression and anxiety to PPD and anxiety patients is that most animal studies 
are restricted to male subjects and there are significant sex differences in depression [41]. 
While it is acknowledged that gene x environment interactions are a significant feature in 
the etiology of depression and anxiety, the environmental components of animal studies 
often lack ethological relevance due to an emphasis on standardization and experimental 
control. Efforts to enhance the experimental control in studies of the role of stress in 
depression have decreased ethological relevance and key cross domain etiology and 
interactions. For example, environmental exposure to stress, a key predictor of depression 
and anxiety, is frequently modeled through the use of chronic restraint, doses of exogenous 
corticosterone, and exposure to a randomized variety of robust stressors in chronic “mild” 
stress paradigms. These types of stressors have substantial physiological components that 
may confound behavioral results and do not mimic important clinical factors, such as social 
stress. Requiring greater cross domain relevance in animal models will increase the 
ethological relevance of animal models and increase the translational effectiveness of novel 
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treatments and preventative measures. While this is a difficult task in many animal models 
and research settings, the study of maternal mood disorders is well-suited to an integrated 
cross domain ethological approach.
One model of PPD and anxiety using the cross domain approach is the chronic social stress 
(CSS) model, which consists of one hour daily exposures of a lactating female to novel 
males for two weeks during lactation [42, 43]. This challenge affects the maternal behavior 
of the stressed dams and also represents an early life stress for the F1 and F2 offspring of 
these dams [44–46]. The specific use of social stress in stress induced depression and 
disease models consistently produces data and conclusions which are particularly clinically 
relevant [47]. It is argued that the use of social stress in the CSS model is essential to the 
effective development of an integrative phenotypic model, since the use other stressors that 
generate changes in affective behaviors could have limited construct validity that may limit 
their ultimate translational value and clinical relevance, even if a cross domain approach is 
used. For example, hours of daily restraint stress may decrease maternal care and increase 
anxiety primarily through a physiological mechanism that is not common in the majority of 
clinical settings. Another example would be decreased maternal care following exposure to 
chronic mild stress paradigm that uses sudden changes in light cycle. A change in maternal 
care in this type of paradigm could be due to a sudden change in light cycle and not the 
chronic array of stressors. A key goal for improving animal models of psychiatric disorders 
is to use ethologically relevant methods to generate clinically relevant changes in both 
behavioral and physiological domains.
In addition to the use of social stress, two other novel aspects of the CSS model are the focus 
on maternal care to measure changes in anhedonia and the inclusion of lactation measures. 
Maternal care is an extremely rewarding behavior for rat dams, who will choose access to 
their pups over cocaine when sensitized to cocaine [48], and human mothers, who are more 
likely to stay in recovery from addiction when kept together with their children [49–51]. 
While most models of PPD and anxiety use standard tests such as forced swim or saccharin 
preference to assess depression associated anhedonia in rodents, maternal care is both a 
more ethologically relevant assessment as well as a clinically important treatment target. 
Some of the greatest concerns about PPD and anxiety are their adverse effects on offspring, 
and these effects are mediated through deficiencies in maternal care [14]. In this way, the 
use of maternal care in the CSS model represents the cross domain approach concept, as the 
domains of anhedonia and offspring care are simultaneously assessed. In a similar fashion, a 
major challenge with PPD associated anxiety for both clinicians and mothers is with the 
adverse effects of anxiety on maternal care [52, 53]. The CSS paradigm attempts to model 
this relationship by using the expression of non-maternal care behaviors expressed during 
maternal care tests (excessive nesting, self-grooming, locomotor activity) as an integrated 
measure of restlessness and anxiety [46]. Instead of standard tests of anxiety such as the 
elevated plus maze, open field, and the light/dark box, where dams are tested away from 
their pups in a novel environment, the assessment of non-maternal behaviors during 
maternal care testing may be a more translationally useful measure of maternal-specific 
anxiety and restlessness. In addition to the benefits of using maternal care to assess 
anhedonia and anxiety, the CSS model includes several other behavioral and physiological 
domains of PPD and anxiety. These include increased aggression in animals actively 
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exposed to chronic social stress [42], impaired decision making, and impaired lactation. 
These behavioral effects are associated with neuroendocrine changes which suggest that 
CSS has etiological and mechanistic similarities with clinical PPD and anxiety, including 
disruptions to the hypothalamic-pituitary-adrenal (HPA) and hypothalamic-pituitary-gonadal 
(HPG) axes [44–46]. CSS decreases maternal care both during active exposure to the social 
stressor during lactation and has more robust effects as an early life stress [44, 46], 
paralleling the transgenerational effects of these disorders [54–56]. Study of the offspring of 
early life CSS exposed dams reveals decreased social behavior in both male and female 
offspring [44], similar to the children of depressed mothers who have an increased risk for 
several disorders which involve deficits in social behavior [14, 56–59]. It is suggested that 
PPD and anxiety are ideal targets for the development of preventative measures for a variety 
of psychiatric illnesses including depression, anxiety, autism, and PTSD, due to its 
substantial developmental importance and associated transgenerational effects.
3. PPD AND ANXIETY AS A RISK FACTOR FOR DEPRESSION AND 
ANXIETY IN OFFSPRING
The next section will briefly review the evidence for neurodevelopmental effects (i.e. motor, 
adaptive, personal-social, language and cognitive) and psychiatric disorders associated with 
maternal antepartum (1) and postpartum (2) depression and anxiety, and discuss evidence of 
proposed cross domain mechanisms by which maternal depression and anxiety/stress is 
transduced from mother to fetus/infant that comes from clinical (3) and animal studies (4).
3.1 Obstetrical and neurodevelopmental effects associated with maternal antepartum 
depression and anxiety
Untreated depression and anxiety during pregnancy pose risks to the health of the pregnancy 
and infant development. Several obstetrical and neonatal complications have been 
implicated as adversely affecting brain development [for a meta-analysis review see 37 
(Alder et al, 2007)]. Antepartum anxiety/stress is associated with preterm birth [60, 61] and 
low birth weight [61, 62], while antepartum depression is associated with inadequate 
maternal weight gain [63] and with increased risks of: preeclampsia [64], paradoxically with 
both preterm birth [62, 65–67] and prolonged pregnancy [68], caesarian delivery [69], 
delivery of a low birth weight infant [66], fetal distress [70] and neonatal care unit 
admission [69]. The risk of poor birth outcomes such as having a low birth weight or small 
for gestational age infant or delivering preterm rises 5–7% for each point increase in 
antepartum depression score as measured by the Beck Depression Inventory [71].
PPD affects the developing fetal autonomic and central nervous systems. Antepartum 
maternal stress, depression, and anxiety have been associated with changes in fetal (in utero) 
heart rate, sleep pattern and movements [72, 73] and alterations in maternal and placental 
stress-related hormones, associate with increased infant fearful temperament [74–76]. In 
neonates, lower scores for the Brazelton Neonatal Assessment Scale, on neurological 
evaluation and cardiac vagal tone are associated with exposure to antepartum maternal 
anxiety/stress [72]. In infants, antepartum depressionis associated with infant growth 
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stunting at age 6–8 months [77] and poorer scores on the Bayley Scales of Infant 
Development at 8 and 24 months age [78, 79].
Antepartum psychosocial stress and maternal cortisol may program infant stress regulation 
by altering stress reactivity. Antepartum stress is associated with elevated maternal 
adrenocorticotropic hormone (ACTH) and cortisol at 28 weeks gestation [80] and elevated 
cortisol in third trimester women with anxiety comorbid with depression [81]. Exposure to 
elevated maternal cortisol during late gestation is associated with exaggerated infant cortisol 
response to a physical stressor and antepartum maternal stress predicts a slower rate of 
behavioral recovery [82]. Higher maternal antepartum cortisol levels are associated with 
poorer infant cognitive performance [83]. Antepartum maternal stress is also associated with 
increased behavioral reactivity in the offspring [84]. Similarly, peripartum maternal 
depression, as opposed to pre-pregnancy history of the disorder, is associated with higher 
infant cortisol reactivity at 6 months of age [85]. Neonates of antepartum depressed mothers 
have higher cortisol levels and lower dopamine and serotonin levels, less optimal 
orientation, motor, autonomic stability, abnormalities in laterality of frontal EEG [86] and 
lower vagal tone compared to neonates born to non-depressed mothers [87]. Infants of 
antepartum depressed mothers also spend more time fussing/crying, spend less time awake/
alert and show more signs of stress behavior than neonates of postpartum depressed or non-
depressed mothers [86]. Neurophysiological differences in antepartum depression exposed 
neonates may reflect not only abnormalities of early brain processing but may predict later 
emotional processing or stress vulnerability, with abnormally asymmetric frontal EEG 
patterns representing a marker of differences in stress response [88] and lower vagal tone as 
an indicator of stress vulnerability [89].
Antepartum depression is associated with infant disorganized attachment at 1 year of age 
[90] and with adverse cognitive development, while high levels of maternal antepartum 
anxiety is associated with poor social-emotional development at 18 months of age [91]. 
Depressive symptoms are associated with lower scores on scales of cognitive development 
and fine motor development [91]. Not surprisingly, antepartum depression may affect male 
and female fetuses differently. Newborns exposed to antepartum depression attain lower 
scores on motor skills than unexposed newborns, with male newborns performing worse 
than females. At 1 year of age, male infants exhibited higher generalized anxiety scores than 
control male infants; both male and female total anxiety scores were higher in the infants 
exposed to antepartum depression compared to unexposed infants. Female infants exposed 
to antepartum depression showed more externalizing behaviors including oppositional/
defiant aggression behaviors than controls, but both sexes exposed to antepartum depression 
had a higher frequency of these behaviors compared to unexposed infants [92].
Antepartum anxiety may increase the risk of childhood developmental and psychiatric 
disorders by adversely affecting infant emotional development [93]. Antepartum maternal 
anxiety is associated with increased child internalizing difficulties age at 7–8 years of age 
while antepartum maternal depression is associated with externalizing difficulties and a 
small decrease in verbal IQ [94]. In children, antepartum anxiety is associated with a greater 
incidence of mixed handedness [95], which has been associated with a range of 
neurodevelopmental problems including dyslexia, ASD and ADHD, possibly indicating that 
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exposure to antepartum anxiety affects another index of neurobehavioral organization, brain 
laterality [95]. Exposure to antepartum maternal anxiety/stress is associated with poorer 
attention, hyperactivity, behavioral and emotional problems in children aged 8–9 years [96] 
and impulsivity during performance of cognitive tasks in 14 and 15 year olds [97]. Across 
gestation, high levels of pregnancy-specific anxiety are associated with lower visuospatial 
working memory performance in boys and girls at 6–9 years age [98] and in girls, inhibitory 
control was impaired. In brain imaging studies, anxiety at 19 weeks gestation is associated 
with region-specific gray matter volume reductions in the prefrontal cortex, premotor cortex, 
medial temporal lobe, lateral temporal cortex, postcentral gyrus and the cerebellum [99].
3.2 Neurodevelopmental effects associated with maternal postpartum depression and 
anxiety
Postpartum depression has been associated with a broad negative impact upon infant and 
child emotional and functional development, including difficult infant and childhood 
temperament [100, 101], attachment insecurity [102], developmental [103] and cognitive 
delays [104], behavioral problems [102], and difficulties with social interaction [105]. 
Maternal depression across the first postpartum year is associated with poor infant social 
engagement, fear regulation, and high stress reactivity [101]. The strongest effects of 
postpartum depression appear to be on early childhood cognitive development, including 
language and intelligence, and on child behavior up to five years postpartum. Children of 
mothers with postpartum depression performed significantly less well on cognitive tasks at 
18 months, especially boys compared to girls and unexposed children [106]. In studies 
which have found cognitive delay in boys born to depressed mothers, low birth weight 
infants are at increased risk. Infants of postpartum depressed mothers have lower cognitive 
scores over the examination period (6–18 months of age), with girls increasing their 
cognitive score as compared to boys, pointing to the importance of looking at the 
contribution of biological sex [107]. Postpartum depression may be associated with poorer 
performance on perceptual, motor and verbal tasks in boys compared to girls or children 
born to non-depressed mothers [108], but not all studies agree [109].
The impact of maternal depression has effects beyond infancy, as one-third of school-aged 
children (ages 5–17 years of age) of depressed mothers suffer from depressive, anxiety or 
disruptive disorders [110]. Some studies of child behavior show correlations between 
postpartum depression and increased child neurotic and antisocial behavior [111] at 5 years 
of age, yet others do not [112]. Postpartum maternal anxiety, similar to antepartum anxiety, 
is associated with increased internalizing problems while postpartum depression is 
associated with increases in internalizing and externalizing problems and a small decrease in 
verbal IQ [94]. No sex differences were noted in this very large (i.e. 3,298 mother-offspring 
pairs) sample. Children of postpartum depressed mothers are more likely than controls to 
experience depression themselves by 16 years age and may be partially explained by 
insecure attachment, low early childhood ego-resilience and by exposure to family adversity 
[113]. In a moderate-sized longitudinal study, maternal antepartum depressive symptoms 
were associated with externalizing problems in children of both sexes and postpartum 
depressive symptoms were associated with lower psychosocial functioning and externalizing 
problems in boys only [114]. In a meta-analysis of 193 studies, maternal depression was 
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significantly related to higher levels of internalizing, externalizing and general 
psychopathology and negative affect/behavior and to lower levels of positive affect/behavior 
[115]. All associations were small in magnitude, highlighting the importance of 
understanding and measuring potential moderators that enhance risk, including timing of the 
exposure (i.e. antepartum, postpartum), the sex of the child, sociodemographic variables, 
etc.. Some studies suggest that exposure to maternal depression during the first year of life, 
rather than a history of the disorder or antepartum depression, predicts internalizing and total 
behavior problems [116], others suggest that chronic maternal depression has longer-lasting 
effects on child development [117]. Since a significant proportion of women with 
postpartum depression go on to develop chronic depression [118], the exposure may in 
many cases be prolonged, affecting several critical periods sensitive to the effects of 
postpartum or chronic depression. However, there is debate whether negative effects of 
postpartum depression are lasting, and some studies find no association between antepartum 
or postpartum depression exposure and neurodevelopmental outcomes [119].
3.3 Transmission of stress-evoked psychopathology risk: Clinical studies
The mechanism through which maternal psychological stress and PPD is transduced from 
the pregnant or postpartum mother to the fetus/infant is unclear, but is likely 
multidimensional. Contributing influences may include interactions between the maternal 
environment in utero, placental changes, epigenetic programming and postpartum 
exposures. In alignment with the fetal origins hypothesis of adaptation and disease, 
programming of physiological systems by the antepartum environment prepares the fetus for 
the postpartum environment. Non-genomic modifications of the phenotype through 
developmental plasticity can offer adaptive value as it aims to match an individual’s 
responses to the environment predicted to be experienced. If the responses are mismatched, 
then the risk of disease increases. When mismatches in environments occur, altered stress 
activity or reactivity may become maladaptive in sex-specific ways [36, 120] and may be 
transmitted to more than the immediately succeeding generation [121].
Antepartum exposure to maternal PPD, anxiety, or stress during sensitive periods of human 
neurodevelopment may contribute to enduring effects on psychological health either through 
the fetus’ direct physiological adaptation to the intrauterine environment or an interaction of 
those effects with inherited genetic risk. The exposure often transverses the antepartum/
postpartum period, so long-term behavioral outcomes are impacted by both environments. 
Dysregulation of the maternal HPA axis, as associated with depression and anxiety, may 
impact fetal development by altering placental function. Increased serum cortisol and 
catecholamine levels may alter uterine blood flow or induce uterine irritability [122] and 
these alterations could initiate early parturition or preterm birth. Additionally, altered gene 
regulation within the placenta has functional consequences for both fetal and infant 
development and is associated with adverse birth outcomes. For example, antepartum 
maternal anxiety is negatively correlated with placental 11β-hydroxysteroid 
dehydrogenase-2 mRNA levels, thus may influence the exposure of the fetus to circulating 
maternal stress hormones [123, 124]. The sexually dimorphic placental sensitivity to stress 
could represent one mechanism for fetal programming in a sex-specific manner [125].
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Antepartum anxiety/stress and depression are associated with HPA axis and epigenetic 
changes in the offspring, a growing literature which has similarities to that which has been 
reported in animal studies [126–128]. Epigenetic modifications may be a mechanistic link 
between maternal adversity and infant and child outcomes [35, 129]. Work in animal 
models, and a more limited but growing literature in human studies, demonstrates that 
epigenetic changes occur in response to environmental stress, some in a sex-specific manner 
[130]. Evidence of epigenetic modification within HPA pathways [131, 132], including the 
glucocorticoid receptor [133] and the serotonin transporter [134] have been identified in 
human offspring. Antepartum stress, for example, could cause alterations in fetal stress 
reactivity [101, 135] and the ability to terminate a stress response through epigenetic 
mechanisms, however it is not known how fetal exposure to stress hormones directly affects 
brain development [136]. The type, duration and timing of the exposure (e.g. 
periconceptional, late gestation vs. postpartum) and underlying genetic and environmental 
risk factors may be important to the later manifestation of sex differences in 
neurodevelopment and/or psychopathology.
Postpartum depression effects may be mediated by maternal behaviors including 
dysfunctional attachment, maternal coping and caregiving behavior, thus indirectly 
increasing the risk for delayed cognitive development and child behavior problems. 
Negative parenting behaviors of depressed mothers range from withdrawal to rejecting, less 
sensitive [101] and harsh parenting [137, 138] while those reported of anxious mothers are 
of being negative and intrusive [101, 139, 140]. Postpartum effects may be moderated in 
part by epigenetic modifications: deprivation of parental care is associated with significant 
epigenetic changes in genes implicated in brain development [141].
3.4 Transmission of stress-evoked psychopathology risk: Animal studies
Some approaches to research of the mother infant bond cannot be employed in humans due 
to their ethical implications and to potential harm they pose for mother and child health. 
Thus, translational approaches are a crucial way to dissect this relationship through bridging 
gaps between basic animal research and medical practice. Translational research approaches, 
with its introduction in the NIH Roadmap initiative [142, 143], have been important in the 
field of psychiatry, and especially to affective disorders, including depression and anxiety-
related disorders. Most efforts have been devoted to the “bench to the bedside” (from 
animals to humans, or from basic to clinical research) approaches focusing on the design of 
animal models (particularly using rodents) that would be relevant to study the human 
disorders and to predict the therapeutic outcomes. Unfortunately, less research follows the 
opposite direction, using the reverse-translational approach and thus going from the bedside 
to the bench (from humans to animals) [144, 145]. However, when trying to assess the 
function of mechanisms discovered in animal models in the pathophysiology of human 
disorders and developing new treatments for these conditions, such reverse-translational 
approaches are crucial. For example, the role of hippocampal neurogenesis in the 
pathophysiology of depression and in the therapeutic efficacy of pharmacological treatments 
has been shown using rodent models [146–148], and then confirmed in human studies [149, 
150]. Research on knockouts and polymorphisms, in animals and humans respectively, at 
the level of the gene for brain-derived neurotrophic factor (BDNF) represents a powerful 
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tool for understanding the involvement of this neurotrophin in the pathogenesis of anxiety 
disorders [151].
Such translational approaches obviously require rodent models that are suitable to study the 
clinical condition. Maternal behavior investigations in animals have proven valuable to 
understand the mother-infant relationship. Maternal behavior in rodents is well-described - 
in brief, it is composed of four major features: retrieval behavior, nest building, nursing 
behavior, and pup grooming. Because these behavioral patterns are well characterized, 
rodent maternal behavior can be quantified in response to various contexts or treatments. 
Numerous studies in rodents and humans demonstrate that the quality of maternal care, and 
early postnatal and prenatal experiences can have long term effects in adulthood on stress 
reactivity and behavior [152]. Mice stressed during early postnatal life show increased 
anxiety-related behaviors, and altered HPA regulation [153]. Rats stressed during prenatal 
life show similar behavioral and endocrine programming [154]. Several animal studies have 
demonstrated the important modifiable reflects of early maternal behaviors [45, 155–158]. 
Notably, changes in maternal care, through CSS, lead to altered neuropeptide regulation in 
the PVN and SON [45]. Meaney and colleague’s studies have linked increased arch back 
nursing, and licking and grooming to enhanced HPA axis feedback regulation and reduced 
anxiety-related behavior through increased glucocorticoid receptor (GR) expression in the 
hippocampus [159]. Translating to the animal literature, clinical studies, as reviewed above, 
find that indices of prenatal stress such as maternal antepartum depression or anxiety also 
predict altered HPA reactivity [160], negative emotionality in infants [161], conduct 
disorders, and emotional problems in children [154, 162]. However, very few studies have 
identified candidates for maternal behaviors in humans that may be the equivalent of rat 
licking and grooming. Strikingly, in rats the effects of the licking and grooming can be 
mimicked by stroking the pups with a brush [154]. Sharp and colleagues recently reported 
the first investigation in humans of moderation of prenatal stress effects by early human 
tactile stimulation on behavioral and physiological stress reactivity in infancy [163]. 
Specifically, they found that the effect of maternal antepartum depression on infant 
reactivity was modified by tactile stimulation over the first weeks of life, assessed by how 
often mothers reported stroking their babies.
Skeptics may suggest that animal models have limited translational relevance to largely 
human specific features, such as maternal behaviors. For instance, in relation to other 
mammals, humans have vastly greater and more complex social competences [164]. 
Variations in well-established dimensions of parenting, such as sensitivity, intrusiveness, or 
hostility with effects on attachment security, emotionality and social attributions may be 
expected to be the most salient for long term effects [165]. Equally, however, long term 
parental effects on multiple physiological systems, are common in biology, and likely to be 
mediated via epigenetic modifications [153, 166]. These may represent an evolved 
capability for environmentally sensitive plasticity over a limited number of generations, 
which could be particularly important in species, such as humans, with lengthy time periods 
between generations and hence only slow genotypic selection in relation to changing 
environmental conditions [154]. Importantly, tactile stimulation derived from parental care 
has immediate effects on endocrine systems that regulate somatic growth in rodents [167], 
and humans [168] suggesting that the ability of the infant to respond to specific forms of 
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parental care is conserved at least among mammals. The genetic mechanisms in 
glucocorticoid regulation are highly conserved across species [169, 170], and so an effect of 
tactile stimulation on GR expression may have been conserved across rodents and humans. 
The examination of dynamic gene expression and epigenetic mechanisms in infants is 
currently limited to peripheral tissue, however against the background of extensive animal 
work demonstrating differences in GR expression and epigenetic regulation, it would be 
important to investigate links between peripheral and CNS gene regulation. Importantly, it 
also needs to be tested whether stroking through skin-to-skin contact is the direct mechanism 
or only a proxy for another causal aspect of parenting. To address these questions it would 
appear imperative to further back-translate findings from human studies to animal models. 
Such translational cross-talk between basic research experiments and the clinic would be 
important to allow fine-tuning of animal models to address such pertinent questions.
4. PPD AND ANXIETY AS A RISK FACTOR FOR AUSTISM SPECTRUM 
DISORDERS IN OFFSPRING
There are several lines of evidence indicating that PPD and anxiety may be a relevant focus 
area for cross domain studies of autism spectrum disorders (ASD). Given the diversity in 
ASD phenotypes and the estimate that the environmental component of autism is 60% [171], 
it is clear that these disorders involve substantial gene by environment interaction. A recent 
study has reported a significantly increased prevalence of ASD in the offspring of mothers 
exposed to high levels of child abuse [172], and the relative risk of ASD has been reported 
to be twice as high in children of mothers who are diagnosed with a psychiatric illness [173]. 
Schizophrenia, depression, and personality disorders are all more common in the mothers of 
autistic children [174]. Parental psychiatric history could represent both a genetic and 
environmental risk [175]. Family members of ASD patients have elevated levels of major 
depression and social phobia that are not explained by the stress of raising an autistic child 
since the majority of depression cases develop prior to the birth of an affected baby [176, 
177]. In animal studies, a genetic link between the lateral septum and medial preoptic area of 
the maternal brain and pathways involved in ASD in rodents has been proposed [178, 179].
Both PPD and ASD involve disruptions in OXT physiology and function. OXT has been 
known to be involved in the control of mammalian social behavior for decades, yet it has 
only recently been targeted as a treatment for human disorders which involve disrupted 
social behaviors. OXT mediates social bonding, anxiety, aggression, and trust in several 
mammals, including humans [180, 181], and decreased OXT during pregnancy is associated 
with an increased risk for postpartum depression [182]. Several studies have documented 
OXT mediated effects of early social environment on social behavior in rodents [183–186], 
and it was concluded that OXT may play a key role in the development of social behavior. 
Elevated basal plasma OXT is associated with distressed pair bonds [187], and increased 
OXT in females correlates with elevated attachment anxiety [188]. Depressed women are 
also more likely to display greater variability in peripheral OXT release in response to a 
stressful situation [189], and higher OXT is associated with elevated anxiety in children with 
high functioning autism as well as healthy controls [190]. Genetic variants in the OXT gene 
(single nucleotide polymorphisms) [191] and altered OXT receptor gene promoter 
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methylation [192] have been implicated in ASD. Intranasal OXT administration improves 
repetitive and social deficits in autistic patients, and is currently being used in clinical trials 
for the treatment of ASD [193]. Induced or augmented births and obstetric complications 
[194, 195] increase the risk of autism in the offspring, which may involve an OXT mediated 
mechanism [196], as a single neonatal OXT treatment (mimicking oxytocin-induced human 
labor) has long term effects on neural dopaminergic and serotonergic systems in rodents 
[197]. Furthermore, early weaning and suboptimal breastfeeding practices are associated 
with increased risk for ASD [198–200] in offspring, and it is postulated that this association 
may involve an insulin growth factor (IGF) deficiency in the newborn [201]. The robust 
associations between ASD, OXT and nursing suggest that the early life stress protocols are 
ideal models for cross domain studies of the role of lactation in ASD, as lactation is 
commonly disrupted in women suffering from postpartum depression and/or anxiety [202–
206]. It is postulated that treatments directed at ensuring maternal health may serve as 
preventative measures for depression, anxiety, and ASD in the offspring of stressed mothers 
and future generations.
The introduction of PPD in a discussion of ASD research also introduces the potential role 
of parental care due to evidence that the adverse psychological effects of postpartum 
depression and anxiety are mediated through deficits in maternal care [14]. When the 
associations between psychiatric illness and maternal depression are combined with studies 
on effective early intervention treatments for ASD that involve intense levels of 
relationship-focused social interaction, it is difficult to discount the significance of a 
potential role for parental behavior in mediating the symptom severity of ASD [207]. These 
early intervention behavioral therapies simulate parental care in many ways, and are often 
administered by both parents and clinicians [208–213]. Targeting maternal care in 
interventions for ASD patients can take full advantage of the earliest possible period for 
intervention, immediately postpartum, and extend treatment beyond prescribed clinical 
treatment sessions. Increased study of ASD and PPD may also reveal important etiological 
mechanisms, for example the role of OXT in social behavior deficits associated with a wide 
range of disorders. Transgenerational study of PPD and anxiety may reveal common 
epigenetic mechanisms given the complex genetic component of both disorders. With the 
increasing ability to identify infants likely to develop autism [214], and the potential 
effectiveness of very early intervention, enhancing the maternal care of ASD patients may 
substantially improve the quality of life of these patients.
Another potentially productive cross domain feature of PPD and ASD is the role of the 
gastrointestinal microbiome. The gut microbiome can mediate an array of social, anxiety 
related, and emotional behaviors in rodents [215] and humans [216] which may involve 
effects on neural development. Gut microbiome-brain interactions facilitate microbe based 
therapies in the treatment of multiple sclerosis and depression in rodent models [217, 218] 
and the adverse emotional effects of chronic fatigue syndrome and psychological distress in 
humans [219, 220]. Furthermore, both early life stress [221] and maternal separation [222] 
alter the gut-brain axis. Studies indicate that the microbiome of ASD patients is altered, and 
manipulating the microbiome in a mouse model of ASD through the feeding of exogenous 
bacteria decreases the display of aberrant anxiety associated behaviors and increases social 
behaviors [223]. This treatment decreases gut permeability, a common symptom in ASD, 
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and it is concluded that there is a gut-microbiome-brain connection in this ASD model. A 
vaccine for Clostridium bootee is currently being developed to treat the GI symptoms of 
autism, and this treatment may have beneficial effects on behavior as well acting through 
central mechanisms [224]. However, it is unclear how the microbiome of ASD patients is 
altered. Significant determinants of GI microbiome early in life, during the time when 
autism develops, are method of birth [225] and breastfeeding [226]. The microbiomes of C-
section and vaginally delivered offspring are significantly different, with C-section births 
lacking some of the bacteria found in vaginally delivered offspring. This difference is not 
ameliorated by breastfeeding. In addition, formula fed babies have different microbiomes 
compared to breastfeed babies [227]. C-sections, birth complications and suboptimal 
breastfeeding have all been associated with ASD [194, 198, 228]. It is postulated that the 
association between birth complications, breastfeeding, and ASD may be mediated through 
changes in gut microbiome, as mothers may transmit the negative effects of stress to the 
offspring through changes in vaginal microbiome and breastfeeding duration that then alter 
the gut microbiome and neural activity of the offspring.
Given the common etiological pathways and symptoms of PPD and anxiety and ASD, 
improved treatments for PPD and anxiety may be effective preventative measures for some 
forms of autism in the offspring of depressed mothers and future generations. However, the 
greatest benefit of cross domain studies on PPD and ASD may be with general 
improvements in social behavior in offspring exposed to PPD and anxiety.
5. PPD AND ANXIETY AS A RISK FACTOR FOR PTSD IN OFFSPRING
There are also increasing links between the pathophysiology of PPD and PTSD, and 
evidence that both of these disorders may benefit from a cross domain approach. For 
example, PTSD is characterized by severe anxiety, hyperarousal, hypervigilance, difficulty 
concentrating, sleep disturbances, re-experiencing trauma, avoidance of trauma-like 
situations, and dissociative amnesia, symptoms which persist long after the initial traumatic 
event [229, 230]. Several of these symptoms are also experienced by mothers with PPD, and 
an estimated 85% of PTSD patients have comorbid disorders, the most common of which 
are depression and substance/alcohol abuse/dependence, and other anxiety disorders [231]. 
In addition, several risk factors for developing PTSD have been identified, including being 
female, prior psychiatric illness, familial history of psychiatric illness, childhood behavioral 
problems, and lack of social support [229, 232–234]. Many of these risk factors are similar 
to those experienced by mothers with PPD and anxiety. Due to the high comorbidity 
between PTSD and depression and since PTSD is more common in females, the same 
women that are especially vulnerable to developing PPD might also be vulnerable to 
developing PTSD after experiencing trauma. Indeed, some researchers have demonstrated 
that PTSD symptomology can explain about half of the variance in postpartum depressive 
symptom scores [235], and suggest that PPD and PTSD may share underlying 
vulnerabilities. Because of the overlapping domains of both PPD and PTSD (e.g. 
hyperarousal; sleep disturbances; anxiety; difficulty concentrating), animal models that can 
specifically target and measure several of these domains may have greater clinical relevance 
to the underlying biological mechanisms of overlapping psychopathologies such as PPD and 
PTSD.
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Children may be more vulnerable to PTSD after exposure to traumatic experiences 
compared to adults [236]. PTSD rates as high as 38% have been reported in war-exposed 
children [237]. Higher rates of PTSD were found in children compared to adults exposed to 
the events of 9/11 on television, and maternal depression was positively associated with 
PTSD symptoms in these children [238]. In addition, mothers of children with PTSD were 
found to have less social support, to be more depressed and anxious, and have more PTSD 
symptoms themselves than mothers of children without PTSD [237]. This could indicate that 
depressed moms and their offspring that are simultaneously exposed to a traumatic event 
might be similarly vulnerable to developing PTSD. Further evidence from offspring of 
Holocaust survivors purports that maternal, but not paternal, PTSD confers increased risk of 
PTSD in offspring, even though increased lifetime risk of PTSD was not found in survivor 
offspring compared to comparison subjects overall [239]. An intergenerational relationship 
between mothers and their offspring has also been demonstrated by Roberts and colleagues 
[240]; children of women with PTSD were found to be more likely to experience traumatic 
events themselves, compared to children of mothers without PTSD. It is possible that the 
intergenerational transmission of PPD and PTSD may involve similar mechanisms.
Mothers with either PTSD or PPD may exhibit similar struggles with maternal care. For 
example, mothers with PTSD have impaired mother-infant bonding [241–243] similar to 
mothers with PPD. Schechter and colleagues [244] found that mothers with PTSD related to 
interpersonal violence exhibited impaired care giving to their children, and reported their 
child’s distress at being separated from them as more stressful than controls. In these 
offspring, the impaired maternal care they receive is likely compounded by witnessing their 
mothers’ traumatic interpersonal violent incident. Mothers with PTSD also display 
significantly more PPD symptoms than moms without PTSD [241]. Complications with 
childbirth itself can also be a traumatic incident that can trigger the onset of postpartum 
PTSD, especially in women with a history of prior traumatic pregnancies or childbirths [245, 
246]. Women with PPD may be particularly vulnerable to perceiving complicated births as 
traumatic, since birth perceptions were demonstrated to be negatively correlated with 
depression scores [247]. Women with a history of multiple pregnancy losses are also more 
likely to have both depression and PTSD than women with a history of only one pregnancy 
loss [248]. Given that poor maternal behavior in infancy has recently been demonstrated to 
negatively affect adult mental health outcomes once the infant reaches 27–33 years of age in 
a 30-year prospective study of inner-city infants born in the U.S. [249], increasing maternal 
behavior as a domain investigated in animal models of PPD and PTSD may critical to the 
development of novel treatment strategies. There are also substantial mechanistic similarities 
between these two disorders.
While studies have produced varying results, it is generally thought that PTSD is marked by 
dysfunction of the HPA axis [250–253]. PTSD manifests when a normal acute stress 
response is unable to be contained, leading to large scale biological alterations in the HPA 
axis in an individual after a traumatic event. Specifically, these biological changes of the 
HPA axis are thought to include increased negative feedback of glucocorticoids resulting in 
overall decreased levels of glucocorticoids like cortisol in the affected individual [253]. 
Types of early life stress in humans that are much more severe than PPD, such as childhood 
maltreatment and abuse, are also associated with hypocortisolism and with an increased risk 
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of developing PTSD in adulthood [254]. In a study by Yehuda and colleagues [255], 
children that had experienced emotional abuse had lower cortisol levels than those without 
emotional abuse experience, especially in children with PTSD. Although maltreatment and 
abuse rarely coincide with PPD, any early life experience that produces similar changes in 
HPA axis function may also increase risk of adult PTSD in offspring. Although depression 
in general is thought to be marked by hypercortisolemia, Harris and colleagues [256] found 
lower evening cortisol levels in women who had developed depression by 5–6 weeks 
postpartum compared to those women who hadn’t developed depression. Furthermore, 
O’Donnell and colleagues [257] found that maternal antepartum mood was associated with 
altered diurnal cortisol in 15 year old children of affected mothers, suggesting 
intergenerational transmission of HPA axis alterations associated with PPD. However, 
cortisol awakening responses of healthy women during pregnancy (38 weeks), but not 
during lactation (6 weeks postpartum) were associated with HPA axis responses to a 
psychosocial stress test given at 8 weeks postpartum, suggesting that HPA axis activity 
during pregnancy is a better predictor of postpartum stress reactivity than HPA axis activity 
during lactation itself [258]. In addition, Essex and colleagues [259] found lower cortisol 
levels in adolescents (age 15) exposed to high maternal depression, although this 
relationship changed if children exhibited symptoms of mental illness themselves. Other 
studies have related inconsistent parenting with changes in cortisol variability [260] and 
higher maternal psychopathology with lower, and more unstable evening cortisol levels in 
children of adoptive parents, importantly suggesting non-genetic, environmental influences 
on HPA axis functioning and stress reactivity in children. It is postulated that women with 
PPD confer an increased risk of mental illnesses such as PTSD to their children by altering 
HPA axis function in infancy.
Evidence from both animal [261–264] and human [230, 255, 259, 260, 265–268] studies 
point to dysregulation of the HPA axis in the link between severe forms of early life 
adversity and stress reactivity later in life. In humans, experiencing trauma as a child can 
have complex effects on HPA axis function; Weems and Carrion [269] observed a 
significant positive relationship between PTSD symptoms and cortisol levels in children 
after recent trauma (within 12 months), but a negative association in these endpoints after 
more distal trauma exposure (occurring more than one year ago). Recent studies have 
investigated the potential that severe forms of early life adversity increase a child’s 
vulnerability for HPA axis dysfunction and PTSD through epigenetic mechanisms [270–
272]. While these types of ELS are not typically experienced by children of mothers with 
PPD and anxiety, there is perhaps a similar role for epigenetics in conferred risk of adult 
mental illness in children of mothers with PPD and anxiety. Animal models that offer more 
translational relevance to early life impaired maternal care, such as early life CSS, are 
critically needed to understand exactly how epigenetic changes occurring through early life 
experience may affect stress reactivity in adulthood. This may then lead to discoveries on 
the underlying transgenerational mechanisms of psychopathologies like PPD and PTSD. 
Although no clinical evidence to date has specifically examined adult risk of PTSD in 
children of mothers with PPD and anxiety, this topic warrants attention, and may lead to 
valuable connections between the underlying biological mechanisms of these disorders.
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5. SUMMARY
Stress associated depression and anxiety, most commonly comorbid in the pregnant mother, 
have adverse effects on several domains in the offspring which serve as risk factors for, or 
represent the earliest manifestation of later stress-evoked psychopathology. In addition, the 
clinical literature supports the hypothesis that depression and anxiety occurring in the 
postpartum period also have adverse effects on several domains of offspring physical and 
mental health. The best studied of these domains include: arousal, cognition, social 
processing and negative valence, however they are usually studied independently of each 
other. Combining multiple domains may be more clinically representative than individual 
study. In addition, while clinical studies have focused on the adverse effects of PPD and 
anxiety on the infant/child, the mechanisms for these effects have not been thoroughly 
studied in humans. Constructs or domains studied in both human neurodevelopment and 
adult psychopathology (e.g. temperament, cognition, arousal, social behavior etc.), are more 
compatible to cross domain mechanistic studies in animal models. Cross domain research 
studies in animal models are therefore ideal for the investigation of specific mechanisms 
involved in PPD and anxiety, and the effects these disorders have on offspring. The key to 
increasing the cross domain component of psychiatric research may be to promote more 
bidirectional interaction between the fields of behavioral ecology, molecular behavioral 
neuroscience, and clinical psychiatry. Multiple types of clinical observations need to be 
carefully considered in the development of animal and human studies aimed at identifying 
mechanisms, treatments, and preventative measures.
6. CONCLUSIONS and FUTURE DIRECTIONS
When possible, it is preferable to prevent rather than treat psychiatric disorders. It is 
suggested that an increase in integrated cross domain studies of PPD and anxiety may 
identify valuable targets for safe and effective preventative measures for 
neurodevelopmental changes and the risk of depression, anxiety, ASD, and PTSD in 
offspring of affected mothers. While addressing psychiatric symptoms in mothers is a 
primary concern for clinicians and researchers, cross domain focus on potential difficulties 
in the mother and offspring may yield substantial preventative benefits for both the children 
of depressed and anxious women and future generations. It has been argued here that cross 
domain research on PPD will benefit from greater ethological relevance in animal work, 
interdisciplinary longitudinal clinical studies, and general increases in direct communication 
and collaboration between animal and clinical researchers. One key objective of an increase 
in communication is to stimulate reverse translational projects that bring novel clinical 
observations back to animal models for detailed mechanistic study. A major clinical need is 
to assess multiple symptoms across the lifespan in developing treatment plans for these 
disorders as well in the long-term evaluation of the effectiveness of these treatments. In 
animal studies, the major needs are increased construct validity in model development and 
the consideration of a more specific timing, and broader range, of symptoms. Increased 
cross domain research on postpartum depression and anxiety in animals and humans both 
within and between disorders will result in more effective preventative translation for 
depression, anxiety, autism, PTSD, and a multitude of other disorders associated with stress 
induced impairments in maternal functioning.
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Research Highlights
• Cross-domain postpartum depression and anxiety studies may identify novel 
preventative measures for psychiatric disorders.
• The study of several psychiatric disorders will benefit from ethologically 
relevant cross domain animal studies.
• Longitudinal cross domain clinical studies are also needed to identify novel 
preventative measures.
• Increased communication between clinicians and animal researchers in the 
development of cross domain studies is needed.
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